MOLI
MOLI (Multi-Omics Late Integration) is a deep learning-based software tool for improved drug response prediction by integrating multiple types of omics data. It takes somatic mutation, copy number aberration, and gene expression data as input and learns features for each data type using type-specific encoding sub-networks.
These learned features are then concatenated into a single representation, which is optimized using a combined cost function consisting of a triplet loss and a binary cross-entropy loss. The triplet loss aims to make the representations of responder samples more similar to each other and different from non-responders. In contrast, the binary cross-entropy loss ensures that the representation is predictive of the response values.
Topic
Machine learning;Oncology;Molecular interactions, pathways and networks
Detail
Operation: Imputation
Software interface: Command-line interface
Language: Python
License: Not stated
Cost: Not stated
Version name: -
Credit: Canada Foundation for Innovation, The Canadian Institutes of Health Research, Terry Fox Foundation, International DFG Research Training Group GRK 1906, the National Science and Engineering Research Council of Canada.
Input: -
Output: -
Contact: Colin C Collins ccollins@prostatecentre.com ,Martin Ester ester@cs.sfu.ca
Collection: -
Maturity: -
Publications
- MOLI: multi-omics late integration with deep neural networks for drug response prediction.
- Sharifi-Noghabi H, et al. MOLI: multi-omics late integration with deep neural networks for drug response prediction. MOLI: multi-omics late integration with deep neural networks for drug response prediction. 2019; 35:i501-i509. doi: 10.1093/bioinformatics/btz318
- https://doi.org/10.1093/BIOINFORMATICS/BTZ318
- PMID: 31510700
- PMC: PMC6612815
Download and documentation
Documentation: https://github.com/hosseinshn/MOLI/blob/master/ISMB_ECCB2019.pdf
Home page: https://github.com/hosseinshn/MOLI
Links: https://github.com/hosseinshn/MOLI/blob/master/README.md
< Back to DB search